Tesamorelin vs Vesugen
FDA Approved vs Moderate Research
synergistic Mechanism-based · 47% Tesamorelin and Vesugen work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.
Molecular Data
Tesamorelin Vesugen
Weight 5,135.9 Da 390 Da
Half-life 26-38 minutes Not established
Chain 44 amino acids 3 amino acids
Type GHRH analog Tripeptide bioregulator
Key Benefits
Tesamorelin
01 FDA-approved formulation
02 Selective visceral fat targeting (15-20% reduction)
03 Proven clinical efficacy
04 Standardized dosing
05 37% liver fat reduction in NAFLD
06 Preserved subcutaneous fat
Vesugen
01 Protects vascular system from aging effects
02 Limits atherosclerosis development
03 Decreases endothelial cell dysfunction
04 Activates SIRT1 anti-aging pathway
05 Enhances stem cell proliferation
06 Reduces cellular senescence markers
07 Reverses SASP phenotype
08 Works synergistically with Cardiogen
Dosing Protocols
Tesamorelin
1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) / Once daily (evening preferred for GH rhythm)
HIV Lipodystrophy (FDA-approved) 1.4mg Once daily
Visceral Fat Reduction 2mg Once daily
Anti-aging/Body Composition 1-2mg 5-7x weekly
NAFLD Treatment 2mg Once daily (12 months)
Cognitive Enhancement 1mg Once daily (20 weeks)
Vesugen
10-20 mg per day (oral capsules) or 10 mg (injectable) / Daily for 10-20 consecutive days (Khavinson bioregulator cycle)
Research protocol 10 mg Daily for 10 days
Side Effects
Tesamorelin
Injection site reactions (17%)
Joint pain (13%)
Water retention
Vesugen
Generally well-tolerated
Minimal side effects reported
Contraindications
Active malignancy
Pituitary disorders
Pregnancy
Active cardiovascular emergencies (seek medical care)
Known hypersensitivity
Pregnancy or breastfeeding
Research Evidence
Tesamorelin Vesugen
Status FDA Approved Moderate Research
References 5 studies 3 studies
Latest June 2025 —
FDA Approved Yes No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.